EN
HI
Summary
As of 11 Nov, 2026, Bafna Pharmaceuticals stock price is ₹472.8. During the trading session, the stock has moved between an intraday low of ₹472.80 and an intraday high of ₹472.80. Over the last 52 weeks, Bafna Pharmaceuticals has traded between ₹94.77 and ₹479.95.
The stock has recorded a trading volume of 505 shares,. Its Average Traded Price (ATP) is ₹472.80, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹472.80.
Bafna Pharmaceuticals has an upper circuit limit of ₹482.25 and a lower circuit limit of ₹463.35. The total value traded stands at ₹2.39 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Bafna Pharmaceuticals also offers a dividend yield of 0%.
Bafna Pharmaceuticals Share Price Chart
Bafna Pharmaceuticals Share Key Metrics
Volume
505.00
Market Cap
1096.59 CR
LTQ@LTP
10@472.80
ATP
472.8
Var Margin
100 %
Circuit Range
463.35-482.25
Delivery %
0 %
Value
2.39 L
ASM/GSM
No
Market Lot
1
Bafna Pharmaceuticals Resistance and Support
Pivot 472.8
Resistance
First Resistance
472.8
Second Resistance
472.8
Third Resistance
472.8
Support
First Support
472.8
Second Support
472.8
Third Support
472.8
Bafna Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 472.79 | 472.79 | 2.00% | 472.79 | 472.79 |
| Sun Nov 08 2026 | 463.54 | 463.54 | 1.99% | 463.54 | 463.54 |
| Fri Nov 06 2026 | 456.5 | 454.5 | 1.56% | 456.5 | 454.39 |
Bafna Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-11 | Quarterly Results |
| 2026-08-11 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Bafna Pharmaceuticals News
Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Intimation for Meeting Scheduled On November 11, 2026
Bafna Pharmaceuticals board will meet on 11 Nov 2026 for financial results.
Nov 06 2026 15:17:36
Bafna Pharmaceuticals Management
| Name | Position |
|---|---|
| Shanmugam Hemalatha | Whole Time Director |
| Vinayak Dinesh Dendukuri | Whole Time Director - Quality |
Bafna Pharmaceuticals Similar Stocks
Gujarat Kidney And Super Speciality Ltd.
154.87
0.00 (0.00%)
Q-Line Biotech Ltd.
516.55
0.00 (0.00%)
GPT Healthcare Ltd.
145.13
0.00 (0.00%)
Bajaj Healthcare Ltd.
315.25
0.00 (0.00%)
Laxmi Dental Ltd.
204.51
0.00 (0.00%)
3B Blackbio Dx Ltd.
1293.60
0.00 (0.00%)
Sigachi Industries Ltd.
27.14
0.00 (0.00%)
Lincoln Pharmaceuticals Ltd.
520.85
0.00 (0.00%)
Anuh Pharma Ltd.
82.78
0.00 (0.00%)
Unihealth Hospitals Ltd.
544.35
0.00 (0.00%)
Bafna Pharmaceuticals FAQs
The Buying Price of Bafna Pharmaceuticals share is 472.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bafna Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bafna Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bafna Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bafna Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bafna Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.97 & 3.82 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bafna Pharmaceuticals is 1096.59 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bafna Pharmaceuticals share price is 479.95 & 94.77. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bafna Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BAFNAPH
